Literature DB >> 24514433

Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.

Qianfeng Zhuang1, Xi Qian, Yunjie Cao, Min Fan, Xianlin Xu, Xiaozhou He.   

Abstract

OBJECTIVE: To investigate the mRNA and protein levels of calpain small subunit-1 (Capn4) in human clear cell renal cell carcinoma (ccRCC), to analyse the relationship between Capn4 mRNA level and pathological stage of ccRCC, and to examine the potential of Capn4 as a prognostic factor in ccRCC.
METHODS: mRNA and protein levels of Capn4 were measured in pairs of tumour tissues and matched adjacent nontumour tissue obtained from patients with ccRCC by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blotting, respectively. Associations of the mRNA level of Capn4 with pathological tumour stage and the overall survival of ccRCC patients were also analysed.
RESULTS: Capn4 mRNA and protein level were significantly higher in ccRCC tumour tissues compared with adjacent nontumour tissues as assessed by qRT-PCR and Western blotting, respectively. Higher Capn4 mRNA levels were observed in patients with more advanced pathological stage of ccRCC and were also associated with decreased overall survival of patients with ccRCC.
CONCLUSIONS: The findings from this study indicate that Capn4 has the potential to be an independent prognostic indicator for ccRCC.

Entities:  

Keywords:  Renal cell carcinoma; calpain; calpain small subunit-1; gene expression; kidney; prognosis

Mesh:

Substances:

Year:  2014        PMID: 24514433     DOI: 10.1177/0300060513505524

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  5 in total

1.  Capn4 promotes non-small cell lung cancer progression via upregulation of matrix metalloproteinase 2.

Authors:  Jie Gu; Feng-kai Xu; Guang-yin Zhao; Chun-lai Lu; Zong-wu Lin; Jian-yong Ding; Di Ge
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

2.  miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4.

Authors:  Haili Hu; Guanghui Wang; Congying Li
Journal:  Onco Targets Ther       Date:  2017-05-23       Impact factor: 4.147

3.  MiRNA-124 regulates the sensitivity of renal cancer cells to cisplatin-induced necroptosis by targeting the CAPN4-CNOT3 axis.

Authors:  Qingyan Mao; Qianfeng Zhuang; Jie Shen; Zhen Chen; Dong Xue; Tao Ding; Xiaozhou He
Journal:  Transl Androl Urol       Date:  2021-09

4.  Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer after Gastrectomy.

Authors:  Peike Peng; Lingqiang Min; Shushu Song; Junjie Zhao; Lili Li; Caiting Yang; Miaomiao Shao; Mingming Zhang; Hao Wu; Jie Zhang; Can Li; Xuefei Wang; Hongshan Wang; Jing Qin; Yuanyuan Ruan; Jianxin Gu
Journal:  Int J Mol Sci       Date:  2016-09-27       Impact factor: 5.923

Review 5.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.